全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Pharmacogenomics and Personalized Medicine

ISSN Print: 1178-7066

ISSN Online:

主页: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journal

分享:




Go

Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report

Tan-kam T, Suthisisang C, Pavasuthipaisit C, Limsila P, Puangpetch A, Sukasem C

Pharmacogenomic considerations in opioid analgesia. [Corrigendum]

Vuilleumier PH, Stamer UM, Landau R

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer

Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF

Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects

Yu X, Kubota T, Dhakal I, Hasegawa S, Williams S, Ozawa S, Kadlubar S

Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects

Yu X,Kubota T,Dhakal I,Hasegawa S

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer

Zhang X,Huang M,Wu X,Kadlubar S

 Pharmacogenomic considerations in opioid analgesia. [Corrigendum]

Vuilleumier PH,Stamer UM,Landau R

Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report

Tan-kam T,Suthisisang C,Pavasuthipaisit C,Limsila P

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies

Sechler M,Cizmic AD,Avasarala S,Van Scoyk M

Role of pharmacogenomics in the treatment of tuberculosis: a review

Ramachandran G, Swaminathan S

Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy

Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM

Drug targets and predictive biomarkers in the management of metastatic melanoma

Thumar J, Giesen E, Kluger HM

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics

Abboudi H, MacPhee IA

Personalized medicine and treatment approaches in non-small-cell lung carcinoma

Vadakara J, Borghaei H

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent

AL-Eitan LN, Jaradat SA, Su SY, Tay GK, Hulse GK

Boceprevir and personalized medicine in hepatitis C virus infection

Habersetzer F, Leboeuf C, Doffo l M, Baumert TF

ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics

Barratt DT, Coller JK, Hallinan R, Byrne A, White JM, Foster DJR, Somogyi AA

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions

Williams PJ, Morgan L

Pharmacogenomic considerations in opioid analgesia

Vuilleumier PH, Stamer UM, Landau R

CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients

Sirachainan E, Jaruhathai S, Trachu N, Panvichian R, Sirisinha T, Ativitavas T, Ratanatharathorn V, Chamnanphon M, Sukasem C

Individualization of antiretroviral therapy

Pavlos R, Phillips EJ

Role of pharmacogenomics in the treatment of tuberculosis: a review

Ramachandran G,Swaminathan S

Pharmacogenomic considerations in opioid analgesia

Vuilleumier PH,Stamer UM,Landau R

Boceprevir and personalized medicine in hepatitis C virus infection

Habersetzer F,Leboeuf C,Doffoël M,Baumert TF

Drug targets and predictive biomarkers in the management of metastatic melanoma

Thumar J,Giesen E,Kluger HM

Personalized medicine and treatment approaches in non-small-cell lung carcinoma

Vadakara J,Borghaei H

ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics

Barratt DT,Coller JK,Hallinan R,Byrne A

The role of genetics in pre-eclampsia and potential pharmacogenomic interventions

Williams PJ,Morgan L

Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy

Kenna GA,Roder-Hanna N,Leggio L,Zywiak WH

CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients

Sirachainan E,Jaruhathai S,Trachu N,Panvichian R

Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent

AL-Eitan LN,Jaradat SA,Su SY,Tay GK

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics

Abboudi H,MacPhee IA

Role of cytochrome P450 genotype in the steps toward personalized drug therapy

Cavallari LH, Jeong H, Bress A

Optimizing response to gefitinib in the treatment of non-small-cell lung cancer

Pietro Carotenuto, Cristin Roma, Anna Maria Rachiglio, et al

Clinical implementation of RNA signatures for pharmacogenomic decision-making

Tang W, Hu Z, Muallem H, Gulley ML

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain

Wallace TJM, Zai CC, Brandl EJ, Müller DJ

ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer

Vaezi A, Feldman CH, Niedernhofer LJ

Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family

Lucire Y, Crotty C

Clinical application of high throughput molecular screening techniques for pharmacogenomics

Wiita AP, Schrijver I

Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1

Edavana VK, Yu X, Dhakal IB, Williams S, Ning B, Cook IT, Caldwell D, Falany CN, Kadlubar S

A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross

Gelinas R, Chesler EJ, Vasconcelos D, Miller DR, Yuan Y, Wang K, Galas D

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy

Bluth MH, Li J

Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1

Edavana VK,Yu X,Dhakal IB,Williams S

Clinical implementation of RNA signatures for pharmacogenomic decision-making

Tang W,Hu Z,Muallem H,Gulley ML

ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer

Vaezi A,Feldman CH,Niedernhofer LJ

A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross

Gelinas R,Chesler EJ,Vasconcelos D,Miller DR

Role of cytochrome P450 genotype in the steps toward personalized drug therapy

Cavallari LH,Jeong H,Bress A

Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain

Wallace TJM,Zai CC,Brandl EJ,Müller DJ

Individualization of antiretroviral therapy

Pavlos R,Phillips EJ

Optimizing response to gefitinib in the treatment of non-small-cell lung cancer

Pietro Carotenuto,Cristin Roma,Anna Maria Rachiglio,et al

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705